Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes
Experimental Lung Research · 09.08.2017 · 43 (6-7) · 271-282
DOI: 10.1080/01902148.2017.1354946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Lung Research, online erschienen am 16.10.2017. Verfasst von Mitsuo Otsuka und 6 weiteren Autor:innen. Beteiligte Einrichtung: a Department of Respiratory Medicine and Allergology , Sapporo Medical University , Sapporo , Japan. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pulmonary fibrosis is a life-threatening pathological state of progressive interstitial lung diseases, such as idiopathic pulmonary fibrosis. Myofibroblasts are known to play a critical role in the pathogenesis of pulmonary fibrosis. This study aimed to evaluate the inhibitory effect of a small interfering RNA (siRNA) on a collagen-specific chaperone heat shock protein 47 (HSP47). The siRNA was preferentially delivered to myofibroblasts in a bleomycin (BLM)-induced pulmonary fibrosis rat model using siRNA against HSP47, encapsulated in a vitamin A-coupled liposome (VA-lip-siRNA HSP47). METHODS AND RESULTS: Male Sprague-Dawley rats were treated with an intratracheal injection of BLM or phosphate buffered saline followed by an intravenous injection of VA-lip-siRNA HSP47 three times per week under preventive administration schedules from day 1 to day 21 and therapeutic administration schedules from day 15 to day 35. The expression of HSP47 after the treatment was assessed by immunoblotting. The specific delivery of VA-lip-siRNA HSP47 conjugated with 6'-carboxyfluoresce into myofibroblasts was examined by immunofluorescence staining. The effect of VA-lip-siRNA HSP47 on fibrosis was analyzed by morphological and biochemical methods. Preferential delivery of VA-lip-siRNA HSP47 to myofibroblasts in fibrotic areas in BLM-treated rats was verified by immunofluorescence staining. Treatment of VA-lip-siRNA HSP47 clearly suppressed HSP47 expression and induced apoptosis of myofibroblasts in the lung of BLM-treated rats. Hydroxyproline levels and inflammatory cytokines in the lungs, and the number of inflammatory cells in the bronchial alveolar lavage of BLM-treated rats were significantly suppressed by the treatment. Morphological assessment showed that VA-lip-siRNA HSP47 also significantly improved the morphological pulmonary fibrosis of BLM-treated rats in both preventive and therapeutic schedules. CONCLUSIONS: These results suggest that VA-lip-siRNA HSP47 improves pulmonary fibrosis in not only preventive, but also therapeutic schedules, and thus, this drug delivery system should provide a novel therapy for refractory pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- a Department of Respiratory Medicine and Allergology , Sapporo Medical University , Sapporo , Japan.
- b Department of Medical Oncology and Hematology , Sapporo Medical University , Sapporo , Japan.
- c Department of Molecular Target Exploration , Sapporo Medical University , Sapporo , Japan.
Zitieren
APA
Otsuka, M., Shiratori, M., Chiba, H., Kuronuma, K., Sato, Y., Niitsu, Y., & Takahashi, H. (2017). Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes. Experimental Lung Research, 43(6-7), 271-282. https://doi.org/10.1080/01902148.2017.1354946
Vancouver
Otsuka M, Shiratori M, Chiba H, Kuronuma K, Sato Y, Niitsu Y, et al. Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes. Experimental Lung Research. 2017;43(6-7):271-282. doi:10.1080/01902148.2017.1354946
BibTeX
@article{Otsuka2017,
author = {Otsuka, Mitsuo and Shiratori, Masanori and Chiba, Hirofumi and Kuronuma, Koji and Sato, Yasushi and Niitsu, Yoshiro and Takahashi, Hiroki},
title = {Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes},
journal = {Experimental Lung Research},
year = {2017},
volume = {43},
number = {6-7},
pages = {271--282},
doi = {10.1080/01902148.2017.1354946}
}
EUVIMED